The FDA's Proposed Opioid Risk Evaluation and Management Strategy (REMS) July 3, 2010 Filed under: Trends-in-Medicine
A Preview of the FDA Advisory Committee on GSK's Avandia July 3, 2010 Filed under: Trends-in-Medicine
FDA Advisory Panel Recommends Approval of First Oral MS DRUG: Novartis’s Gilenia (fingolimod) June 27, 2010 Filed under: Trends-in-Medicine
FDA Advisory Panel Clears the Use of GSK's Rotarix and Merck's RotaTeq June 3, 2010 Filed under: Trends-in-Medicine